Mode
Text Size
Log in / Sign up

Bedtime antihypertensive dosing shows no cardiovascular benefit over morning dosingBedtime vs. Morning Blood Pressure Meds: No Clear Winner

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider timing of antihypertensives based on patient preference; bedtime dosing does not reduce cardiovascular events vs morning dosing.

This meta-analysis pooled data from randomized controlled trials comparing bedtime versus morning administration of antihypertensive medications. The primary outcome was major adverse cardiovascular events (MACE), including cardiovascular death, myocardial infarction, stroke, and hospitalization for heart failure. The analysis found no evidence of an association between dosing time and risk reduction for MACE or any secondary outcomes such as all-cause death, stroke, or myocardial infarction.

The authors observed that the confidence intervals for all outcomes were wide, indicating imprecision. The median follow-up across trials ranged from just over one year to more than six years. Limitations noted include potential heterogeneity in study designs and populations, as well as variability in the definitions of morning and bedtime dosing.

Clinicians should interpret these findings cautiously. While some prior observational studies suggested a benefit with bedtime dosing, this meta-analysis of randomized data does not support a difference in cardiovascular outcomes. The choice of dosing time may be guided by patient convenience, adherence, and tolerability rather than anticipated cardiovascular benefit.

If you take medication for high blood pressure, you may have wondered whether it matters if you take it in the morning or at bedtime. A new analysis combining results from several high-quality studies looked at this question. The analysis included data from 46,477 people who were part of randomized controlled trials. These trials compared taking blood pressure pills at bedtime versus taking them in the morning. The goal was to see if bedtime dosing could better prevent major heart problems like heart attacks, strokes, heart failure, or death.

The researchers found no clear evidence that taking medication at bedtime was better than taking it in the morning. They looked at a combined outcome called major adverse cardiovascular events (MACE), which includes death from any cause or from heart disease, heart attack, stroke, and hospitalization for heart failure. The results showed that the risk of these events was similar whether people took their medication at bedtime or in the morning. The same was true when each type of event was looked at separately: all-cause death, cardiovascular death, stroke, heart attack, and hospitalization for heart failure.

It is important to understand that the results do not prove that bedtime dosing is harmful or useless. Instead, they suggest that the timing of medication may not make a big difference for most people. The studies included in this analysis followed patients for an average of 1 to 6 years. This is a long enough time to see differences if they existed. However, the results were not strong enough to say that one timing is better than the other.

One reason for the lack of clear difference could be that blood pressure medications work well regardless of when you take them, as long as you take them every day. Another reason is that people's blood pressure patterns vary. Some people have a natural dip in blood pressure at night, while others do not. The studies did not separate people based on these patterns. So, it is possible that some people might benefit from bedtime dosing, but the overall effect is small.

For now, the most important thing is to take your blood pressure medication every day as prescribed. If you have trouble remembering, choose a time that works best for you and stick with it. Talk to your doctor if you have questions about the best time for your specific situation. This analysis suggests that for the average person, the timing of medication is less important than taking it consistently.

In summary, this large analysis did not find a benefit to taking blood pressure medication at bedtime compared to morning. The risk of heart attacks, strokes, and death was similar with both timings. Patients should focus on taking their medication daily and discuss any concerns with their healthcare provider.

What this means for you:
Taking blood pressure meds at bedtime does not lower heart risks more than morning dosing.

Study Details

Study typeMeta analysis
Sample sizen = 46,477
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
BACKGROUND: Antihypertensive medications are essential for preventing cardiovascular events and have traditionally been taken in the morning. However, recent studies have suggested that taking the medication at bedtime may be more effective in reducing cardiovascular risk. This study aimed to examine the association between dosing time and cardiovascular outcomes. METHODS: Randomized controlled trials were retrieved through a systematic literature review using PubMed and Embase. The primary outcome was major adverse cardiovascular events (MACE), defined as a composite of all-cause (or cardiovascular) death, myocardial infarction, stroke, and hospitalization for heart failure. Secondary outcomes included each component of the primary outcome. A random-effects model was applied to calculate the pooled hazard ratio (HR) for each outcome. RESULTS: Five randomized controlled trials with 46,477 participants (bedtime, 23,178; morning, 23,299) were included. The median follow-up period ranged from 1.1 to 6.3 years, and the mean or median age ranged from 55.6 to 88 years. We found no evidence that bedtime antihypertensives administration was associated with the risk of MACE [HR = 0.71; 95% confidence interval (CI), 0.43-1.16], all-cause death (HR = 0.76; 95% CI, 0.49-1.17), stroke (HR = 0.70; 95% CI, 0.39-1.23), myocardial infarction (HR = 0.88; 95% CI, 0.56-1.38), or hospitalization for heart failure (HR = 0.58; 95% CI, 0.26-1.33), compared to morning administration. CONCLUSIONS: Administration of antihypertensives at bedtime was not significantly associated with a lower incidence of cardiovascular outcomes in comparison with administration in the morning.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.